[1]
Çetin, İdil and Topçul, M. 2022. Antiproliferative Effects of EGFR inhibitor Cetuximab and PARP Inhibitor Combination on Non-Small Cell Lung Cancer Cell Line A549 and Cervical Cancer Cell Line HeLa : Effects of Combination of EGFR inhibitor Cetuximab and PARP inhibitor. Cellular and Molecular Biology. 68, 8 (Aug. 2022), 47–51. DOI:https://doi.org/10.14715/cmb/2022.68.8.8.